reports
LivaNova Reports First-Quarter 2024 Results
LONDON--(BUSINESS WIRE)-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended March 31, 2024 and raised full-year 2024 revenue and adjusted diluted earnings per share guidance. Financial Summary and Highlights(1) First-quarter revenue of $294.9 million increased 12.0% on a reported basis and 12.4% on a constant-currency basis, as compared to the prior-year period. Excluding the impact of the Advanced Circulatory Support (ACS) segment wind down, revenue increased 13.5% on a constant-currency basis First-quarter U.S. GAAP...
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
LONDON--(BUSINESS WIRE)-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Ahmet Tezel, Ph.D., will join the Company as Chief Innovation Officer (CINO), effective May 13, 2024. In this newly created position, Tezel will leverage his career of more than 20 years in research and development (R&D) to establish an integrated innovation function at LivaNova that will accelerate the Company’s development of new technologies. In this capacity, Tezel will join the LivaNova Executive Leadership Team. “I am very pleased to welcome Ahmet to the LivaNova team. At...
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incide...
LONDON--(BUSINESS WIRE)-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that its wholly-owned U.S. subsidiary, LivaNova USA, Inc., is providing notice to U.S. patients regarding a cybersecurity incident that was initially disclosed by the Company on November 20, 2023. The incident resulted in a disruption to portions of the Company’s information technology systems. Promptly after detecting the issue on November 19, 2023, LivaNova began an investigation with assistance from external cybersecurity experts and coordinated with law enforcement. The Com...
American Airlines Reports First-Quarter 2024 Financial Results
American Airlines Reports First-Quarter 2024 Financial Results FORT WORTH, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- American Airlines Group Inc. (NASDAQ: AAL) today reported its first-quarter 2024 financial results, including: Record first-quarter revenue of approximately $12.6 billion.First-quarter net loss of $312 million, or ($0.48) per diluted share. Excluding net special items1, first-quarter net loss of $226 million, or ($0.34) per diluted share.Achieved best-ever first-quarter completion factor. Generated operating cash flow of $2.2 billion and free cash flow2 of $1.4 billion in ...
MeiraGTx to Participate in Upcoming Investor Conferences
MeiraGTx to Participate in Upcoming Investor Conferences LONDON and NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief Executive Officer, will participate in the following investor conferences: Chardan 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit, Virtual Corporate presentation: Monday, April 29, 2024, at 11:00 a.m. ET BofA Securities Healthcare Conference 2024, Las Vegas Corporate presentation: ...
Ageas and BNP Paribas: Transparency notification
Ageas and BNP Paribas: Transparency notification Ageas and BNP Paribas: Transparency notification In accordance with the rules on financial transparency*, BNP Paribas has notified Ageas on 22 April 2024 that, on 19 April 2024, its interest has exceeded the legal threshold of 5% of the shares issued by Ageas. Its current shareholding stands at 6.65%. Reason for the notificationAcquisition or disposal of voting securities or voting rights Notification byA parent undertaking or a controlling person Persons subject to the notification requirementSee annex 1a D...
Ageas and Fosun: Transparency notification
Ageas and Fosun: Transparency notification Ageas and Fosun: Transparency notification In accordance with the rules on financial transparency*, Fosun has notified Ageas on 22 April 2024 that, on 19 April 2024, its interest has fallen below the legal threshold of 5% of the shares issued by Ageas. Its current shareholding stands at 4.64%. Reason for the notificationAcquisition or disposal of voting securities or voting rights Notification byA parent undertaking or a controlling person Persons subject to the notification requirementSee annex 1a. Date on which the threshold is crossed19 Apr...
Ageas et Fosun: Notification de transparence
Ageas et Fosun: Notification de transparence Ageas et Fosun: Notification de transparence Conformément aux règles de transparence financière*, Fosun a introduit le 22 avril 2024 une notification annonçant que, le 19 avril 2024, sa participation a franchi, à la baisse, le seuil légal de 5% des actions émises par Ageas et atteint 4,64%. Motif de la notificationAcquisition ou cession de titres conférant le droit de vote ou de droits de vote Notification parUne entreprise mère ou une personne détenant le controle Personne(s) tenue(s) à notificationVoir annexe 1a. Date de dépassement du seu...
Ageas en Fosun: Transparantiekennisgeving
Ageas en Fosun: Transparantiekennisgeving Ageas en Fosun: Transparantiekennisgeving Fosun informeerde Ageas op 22 april 2024, overeenkomstig de financiële transparantievereisten*, dat zijn belang op 19 april 2024 onder de wettelijke drempel van 5% van de door Ageas uitgegeven aandelen is gedaald en nu 4,64% bedraagt. Reden van de kennisgevingVerwerving of overdracht van stemrechtverlenende effecten of stemrechten Kennisgeving doorEen moederonderneming of een controlerende persoon Kennisgevingsplichtige perso(o)n(en)Zie bijlage 1a. Datum van drempeloverschrijding19 april 2024 Overschre...
MeiraGTx Announces Oral Presentation at the 2024 American Academy of O...
MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference LONDON and NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the Company gave an oral presentation at the American Academy of Oral Medicine Annual Conference, being held from April 16-20, 2024, at the Hyatt Regency Grand Cypress in Orlando, FL. The details of the oral presentation are below: Session: Oral Abstract Session IPresentation ID #196Title: Results of a Phase 1, ...
Lantheus to Host First Quarter 2024 Earnings Conference Call and Webca...
Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, May 2, 2024, to discuss its financial and operating results for the first quarter of 2024. To access the conference call or webcast, participants should register online at . To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time. A replay will be avai...
The Children’s Place Announces $90 Million in New Unsecured Financing ...
The Children’s Place Announces $90 Million in New Unsecured Financing Provided by Majority Shareholder Mithaq Capital Upon Funding, a Waiver of the Event of Default Triggered by the Change in Control Will Be Granted SECAUCUS, N.J., April 17, 2024 (GLOBE NEWSWIRE) -- The Children’s Place, Inc. (Nasdaq: PLCE), an omni-channel children’s specialty portfolio of brands with an industry-leading digital-first model, today announced that it has entered into a new financing agreement with its majority shareholder, Mithaq Capital SPC (“Mithaq”), for an unsecured and subordinated $90 million term...
- Carole Braudeau
- Carole Braudeau
- Hilde Van Boxstael
- Jacob Mekhael
- Kristof Samoy
- Michiel Declercq
- Thomas Couvreur
- Thomas Vranken
- Wim Lewi
Ageas announces the Ordinary and Extraordinary General Meetings of Sha...
Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV As the quorum required for the Extraordinary General Meeting of Shareholders of Wednesday 17 April 2024 will not be attained, ageas SA/NV is organising the Ordinary and Extraordinary Meetings of Shareholders (the "Meeting") on Wednesday 15 May 2024 at 10:30 a.m. The Meeting is being held at the Auditorium of AG Insurance, AG Campus, in 1000 Brussels, Rue du Pont Neuf 17. The general conditions for att...
Ageas annonce les Assemblées Générales Ordinaire et Extraordinaire des...
Ageas annonce les Assemblées Générales Ordinaire et Extraordinaire des Actionnaires d’ageas SA/NV Ageas annonce les Assemblées Générales Ordinaire et Extraordinaire des Actionnaires d’ageas SA/NV Étant donné que le quorum requis pour l’Assemblée Générale Extraordinaire des Actionnaires du mercredi 17 avril 2024 ne sera pas atteint, ageas SA/NV organisera les Assemblées Générales Ordinaire et Extraordinaire des Actionnaires (« l’Assemblée ») le mercredi 15 mai 2024 à 10h30. L’Assemblée se tiendra à l’Auditorium d’AG Insurance, AG Campus, Rue du Pont Neuf 17 à 1000 Bruxelles. Les modalités ...
Ageas kondigt de Gewone en Buitengewone Algemene Vergaderingen van Aan...
Ageas kondigt de Gewone en Buitengewone Algemene Vergaderingen van Aandeelhouders van ageas SA/NV aan Ageas kondigt de Gewone en Buitengewone Algemene Vergaderingen van Aandeelhouders van ageas SA/NV aan Aangezien het vereiste quorum voor de Buitengewone Algemene Vergadering van Aandeelhouders van woensdag 17 april 2024 niet zal worden bereikt, organiseert ageas SA/NV op woensdag 15 mei 2024 om 10u30 de Gewone en Buitengewone Algemene Vergaderingen van Aandeelhouders (de “Vergadering”). De Vergadering zal plaatsvinden in het Auditorium van AG Insurance, AG Campus, Nieuwbrug 17, te 1000 Bru...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.